Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
Open Access
- 23 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 8
Abstract
Background: Surgery is not generally recommended for non-small cell lung cancer (NSCLC) patients with malignant pleural dissemination (PD). However, in some cases, PD is found unexpectedly during surgery. There is no consensus on whether surgical intervention can provide survival benefit for them. We investigated the role of surgery in NSCLC patients with unexpected PD by a cohort study.Methods: Clinical data of consecutive patients who intended to undergo radical surgery for NSCLC between January 2010 and December 2015 at Shanghai Chest Hospital and Huadong Hospital were collected from a lung cancer database. Patients diagnosed with unexpected malignant pleural nodules intraoperatively were enrolled in this retrospective study.Results: A total of 181 NSCLC patients were diagnosed with unexpected malignant PD intraoperatively and confirmed with postoperatively histological examinations. Out of these, 80 (44.2%) patients received pleural nodule biopsies alone, and 101 (55.8%) received primary tumor resection (47 with sublobar resection and 54 with lobectomy). The median progression-free survival and overall survival for all patients were 13 and 41 months respectively. Patients in the resection group had significantly better progression-free survival (19.0 vs. 10.0 months, P < 0.0001) and overall survival (48.0 vs. 33.0 months, P < 0.0001) than patients in the biopsy group. In the resection group, there was no statistical difference between patients with sublobar resection and lobectomy (P = 0.34). Univariate and multivariate analyses identified primary tumor resection, targeted adjuvant therapy, and tumor size (≤ 3 cm) as independent prognostic factors.Conclusions: NSCLC patients with unexpected intraoperative PD potentially benefited from surgical resection of the primary tumor and multidisciplinary targeted therapy, particularly when tumor size did not exceed 3 cm. Our data demonstrated that the resection type was not associated with survival differences, which remains to be defined with a larger sample size.Keywords
This publication has 26 references indexed in Scilit:
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020Journal of the National Comprehensive Cancer Network, 2019
- Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer PatientsMedicine, 2016
- Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural disseminationInteractive CardioVascular and Thoracic Surgery, 2015
- Surgical Outcomes after Pulmonary Resection for Non–Small Cell Lung Cancer with Localized Pleural Seeding First Detected during SurgeryThe Thoracic and Cardiovascular Surgeon, 2015
- The IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2015
- Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center StudyThe Thoracic and Cardiovascular Surgeon, 2015
- Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomyEuropean Journal of Cardio-Thoracic Surgery, 2011
- Validation Study of the Proposed IASLC Staging Revisions of the T4 and M Non-small Cell Lung Cancer Descriptors Using Data from 23,583 Patients in the California Cancer RegistryJournal of Thoracic Oncology, 2008
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung CancerJournal of Thoracic Oncology, 2007
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2007